| MedLumics. (2/10/21). "Press Release: MedLumics Closes Upsized EUR 18M (21.7M USD) Financing Round and Appoints New Chairman". Madrid. |
2021-02-10 |
| MeiraGTx Holdings plc. (1/31/19). "Press Release: MeiraGTx Enters into Strategic Collaboration with Janssen to Develop and Commercialize Gene Therapy Treatments for Inherited Retinal Diseases". London & New York, NY. |
2019-01-31 |
| MeiraGTx Holdings plc. (10/16/18). "Press Release: MeiraGTx Enters Collaboration with Johnson & Johnson Innovation to Develop Regulatable Gene Therapy Treatment using MeiraGTx Riboswitch Technology". London & New York, NY. |
2018-10-16 |
| MeiraGTx Holdings plc. (10/25/18). "Press Release: MeiraGTx Expands Leadership Team with Appointment of Katherine Breedis as Chief Financial Officer". London & New York, NY. |
2018-10-25 |
| MeiraGTx Holdings plc. (10/30/23). "Press Release: MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic Opportunities". London & New York, NY. |
2023-10-30 |
| MeiraGTx Holdings plc. (10/9/18). "Press Release: MeiraGTx Announces Acquisition of Vector Neurosciences, Gains Phase 2 Gene Therapy Program for Parkinson’s Disease". London & New York. |
2018-10-09 |
| MeiraGTx Holdings plc. (11/19/20). "Press Release: MeiraGTx Announces Pricing of Public Offering of Ordinary Shares". London & New York, NY. |
2020-11-19 |
| MeiraGTx Holdings plc. (12/19/17). "Press Release: MeiraGTx Announces Gene Therapy Manufacturing Collaboration with Oxford Genetics". London & New York, NY. |
2017-12-19 |
| MeiraGTx Holdings plc. (2/27/19). "Press Release: MeiraGTx Announces $80 Million Private Placement of Ordinary Shares". London & New York, NY. |
2019-02-27 |
| MeiraGTx Holdings plc. (3/26/19). "Press Release: MeiraGTx Reports Full Year 2018 Financial Results". London & New York, NY. |
2019-03-26 |
| MeiraGTx Holdings plc. (3/31/17). "Press Release: MeiraGTx Announces Opening of European Technology Hub". Leiden. |
2017-03-31 |
| MeiraGTx Holdings plc. (4/25/19). "Press Release: MeiraGTx Announces Upcoming Presentation on Achromatopsia Gene Therapy Candidate AAV-CNGA3 at ARVO 2019". London & New York, NY. |
2019-04-25 |
| MeiraGTx Holdings plc. (5/10/19). "Press Release: MeiraGTx Appoints Nicole Seligman to Board of Directors". London & New York, NY. |
2019-05-10 |
| MeiraGTx Holdings plc. (5/14/19). "Press Release: MeiraGTx Announces Positive 6-Month Data from Phase 1/2 Trial of Investigational Gene Therapy AAV-RPE65 for RPE65-Deficiency". London & New York, NY. |
2019-05-14 |
| MeiraGTx Holdings plc. (5/14/19). "Press Release: MeiraGTx Reports First Quarter 2019 Financial Results and Provides Corporate Update". London & New York, NY. |
2019-05-14 |
| MeiraGTx Holdings plc. (6/12/18). "Press Release: MeiraGTx Announces Closing of Initial Public Offering". London & New York, NY. |
2018-06-12 |
| MeiraGTx Holdings plc. (6/7/18). "Press Release: MeiraGTx Announces Pricing of Initial Public Offering". London & New York, NY. |
2018-06-07 |
| MeiraGTx Holdings plc. (8/7/19). "Press Release: MeiraGTx Announces Proposed Public Offering of Ordinary Shares". London & New York, NY. |
2019-08-07 |
| MeiraGTx Holdings plc. (8/7/19). "Press Release: MeiraGTx Reports Second Quarter 2019 Financial Results and Provides Corporate Update". London & New York, NY. |
2019-08-07 |
| MeiraGTx Holdings plc. (8/8/19). "Press Release: MeiraGTx Announces Pricing of Public Offering of Ordinary Shares". London & New York, NY. |
2019-08-08 |
| MeiraGTx Holdings plc. (9/8/22). "Press Release: MeiraGTx to Participate in Upcoming Investor Conferences". London & New York, NY. |
2022-09-08 |
| Memo Therapeutics AG. (11/02/23). "Press Release: Memo Therapeutics AG Raises CHF 25 Million Series C Financing to Complete Phase II Clinical Development of AntiBKV for BKV Infection in Renal Transplant Patients". Schlieren. |
2023-11-02 |
| Memo Therapeutics AG. (11/5/20). "Press Release: Memo Therapeutics AG Raises CHF 14 Million in a Series B Financing Round". Schlieren. |
2020-11-05 |
| Memo Therapeutics AG. (5/9/18). "Press Release: Memo Therapeutics AG Closes Series A2 Financing Round of CHF 5 Million to Advance Its Antibody Discovery Programs into Preclinical and Clinical Development". Basel. |
2018-05-09 |
| Mercia Technologies plc. (1/25/18). "Press Release: Clinical Trials Software Secures £500k Investment from Mercia". |
2018-01-25 |
| Mercia Technologies plc. (5/2/18). "Press Release: Mercia’s First University of Edinburgh Investment Offers Dialysis Hope". |
2018-05-02 |
| Merck & Co., Inc.. (11/21/23). "Press Release: Merck to Acquire Caraway Therapeutics, Inc.". Rahway, NJ & Cambridge, MA. |
2023-11-21 |
| Merck & Co., Inc.. (12/21/22). "Press Release: Lynparza (olaparib) in Combination With Abiraterone and Prednisone or Prednisolone Approved in the EU as Treatment for Certain Patients With Metastatic Castration-Resistant Prostate Cancer". Rahway, NJ. |
2022-12-21 |
| Merck & Co., Inc.. (3/24/21). "Press Release: Merck Appoints Caroline Litchfield Chief Financial Officer". Kenilworth, NJ. |
2021-03-24 |
| Merck & Co., Inc.. (8/7/17). "Press Release: MSD Animal Health to Purchase Manufacturing Facility in Krems, Austria. European Facility Will Boost Global Vaccine Production Capacity". Madison, NJ. |
2017-08-07 |
| Merck KGaA. (1/23/17). "Press Release: Merck Announces Emerging Biotech Grant Program Winners". Darmstadt. |
2017-01-23 |
| Merck KGaA. (10/10/19). "Press Release: Merck Becomes the First to Use Acoustic Technology for Cell Therapy Manufacturing". Darmstadt. |
2019-10-10 |
| Merck KGaA. (10/8/20). "Press Release: Merck Celebrates Topping-Out Ceremony for New Membrane Production Plant". Darmstadt. |
2020-10-08 |
| Merck KGaA. (3/2/17). "Press Release: NICE Expands Positive Recommendation for Erbitux as First-line Treatment for RAS Wild-type mCRC". Darmstadt. |
2017-03-02 |
| Merck KGaA. (4/24/19). "Press Release: Merck Introduces New Greener Solvent, Cyrene". Darmstadt. |
2019-04-24 |
| Merck KGaA. (4/26/19). "Press Release: Merck Presents Plans for Future Growth to Shareholders. 24th Annual General Meeting in Frankfurt am Main". Frankfurt a. M.. |
2019-04-26 |
| Merck KGaA. (6/15/17). "Press Release: Merck Expands Distribution Agreement with Public Health England". Darmstadt. |
2017-06-15 |
| Merck KGaA. (6/19/18). "Press Release: Merck Signs Exclusive Agreement with HistoCyte Laboratories to Distribute Pathology Technology". Darmstadt. |
2018-06-19 |
| Merck KGaA. (6/20/17). "Press Release: Merck Ventures Creates New Immuno-Oncology Company iOnctura". Darmstadt. |
2017-06-20 |
| Merck KGaA. (8/23/21). "Press Release: Merck Statement on Phase II Study of Bintrafusp Alfa in First-Line Treatment of Biliary Tract Cancer". Darmstadt. |
2021-08-23 |
| Merck KGaA. (8/3/17). "Press Relase: European Patent Office to Grant Merck’s Patent Application for CRISPR Technology". Darmstadt. |
2017-08-03 |
| Merck KGaA. (9/20/23). "Press Release: Merck Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery [Not intended for US-, Canada- or UK-based media]". Darmstadt. |
2023-09-20 |
| Merck KGaA. (9/21/22). "Press Release: Merck Opens New € 29 Million Biologics Testing Center in Shanghai". Shanghai. |
2022-09-21 |
| Merck KGaA. (9/22/21). "Press Release: Sabia Schwarzer Appointed Head of Group Communications, Brand and Corporate Affairs at Merck". Darmstadt. |
2021-09-22 |
| MerLion Pharmaceuticals Pte. Ltd.. (6/28/17). "Press Release: MerLion and Dstl Awarded DTRA Grant to Explore the Use of Finafloxacin against Biological Threat Agents". Singapore. |
2017-06-28 |
| Merus N.V.. (1/7/21). "Press Release: Merus Granted FDA Fast Track Designation of Zenocutuzumab for the Treatment of Patients with Neuregulin 1 Fusion Cancers". Utrecht & Cambridge, MA. |
2021-01-07 |
| Mesenbio Ltd.. (1/9/24). "Press Release: DSW Ventures and NG Bio Lead £1.4m Investment into University of York Spinout Mesenbio". |
2024-01-09 |
| Mestag Therapeutics Ltd.. (4/20/21). "Press Release: Mestag Therapeutics Launches with Seed Financing of $11 Million to Develop Therapeutics Targeting Activated Fibroblast Populations across Inflammatory Disease and Cancer". Cambridge. |
2021-04-20 |
| Mestag Therapeutics Ltd.. (5/18/21). "Press Release: Mestag Therapeutics Announces Collaboration with Janssen, Focused on the Discovery of Novel Fibroblast Targets for the Treatment of Inflammatory Disease". Cambridge. |
2021-05-18 |
| Mestag Therapeutics Ltd.. (8/3/21). "Press Release: Mestag Therapeutics Extends Seed Financing to $45 Million and Welcomes New Investors Forbion, GV (formerly Google Ventures) and Northpond Ventures". Cambridge. |
2021-08-03 |
| Metagenomi Inc.. (1/25/22). "Press Release: Metagenomi Closes Oversubscribed $175M Series B Financing to Advance Therapeutic Pipeline and Expand Novel Gene Editing Platform". Emeryville, CA. |
2022-01-25 |
| Metrion Biosciences Ltd.. (1/16/18). "Press Release: Metrion Biosciences Opens £600k Investment Round through SyndicateRoom to Support Growth of Services Business". Cambridge. |
2018-01-16 |
| Metrion Biosciences Ltd.. (1/29/18). "Press Release: Metrion Biosciences Acquires Rights to Small Molecule Potassium Channel Inhibitors from Japan Tobacco Inc.". Cambridge. |
2018-01-29 |
| Metrion Biosciences Ltd.. (12/16/21). "Press Release: Metrion Biosciences and Bioqube Ventures Collaborate on Venture Creation Project to Identify novel ion channel inhibitors for autoimmune diseases". Cambridge & Brussels. |
2021-12-16 |
| Metrion Biosciences Ltd.. (12/20/23). "Press Release: Metrion Biosciences Closes £3.7m New Equity Financing". Cambridge. |
2023-12-20 |
| Metrion Biosciences Ltd.. (2/12/18). "Press Release: Metrion Biosciences Establishes Scientific Advisory Board". Cambridge. |
2018-02-12 |
| Metrion Biosciences Ltd.. (2/5/18). "Press Release: Metrion Biosciences Awarded £200k Funding under Innovate UK Biomedical Catalyst Feasibility Award". Cambridge. |
2018-02-05 |
| Metrion Biosciences Ltd.. (4/1/19). "Press Release: Metrion Biosciences Closes Funding Round. Includes investment from o2h Ventures Therapeutics Fund". Cambridge. |
2019-04-01 |
| Metrion Biosciences Ltd.. (4/24/17). "Press Release: Metrion Biosciences and Venomtech Announce Research Collaboration". Cambridge. |
2017-04-24 |
| Metrion Biosciences Ltd.. (4/6/21). "Press Release: Metrion Biosciences Closes £2.7m New Equity Financing. Financing Led by Gresham House Ventures". Cambridge. |
2021-04-06 |
| Metrion Biosciences Ltd.. (4/8/19). "Press Release: Metrion Biosciences Appoints Dr Andrew Southan as Chief Executive Officer". Cambridge. |
2019-04-08 |
| Metrion Biosciences Ltd.. (5/2/17). "Press Release: Metrion Biosciences Appoints Chief Operating Officer and Head of Business Development". Cambridge. |
2017-05-02 |
| Metrion Biosciences Ltd.. (6/9/22). "Press Release: Metrion Biosciences Appoints Dr Benedetta Montagnini as Head of European Business Development". Cambridge. |
2022-06-09 |
| Metrion Biosciences Ltd.. (7/26/21). "Press Release: Metrion Biosciences Appoints Nick Foster as Chief Commercial Officer and Head of Global Business Development". Cambridge. |
2021-07-26 |
| Metrion Biosciences Ltd.. (9/17/18). "Press Release: Metrion Biosciences Makes Senior Appointments to Strengthen Its Drug Discovery Leadership tTeam". Cambridge. |
2018-09-17 |
| Metrion Biosciences Ltd.. (9/8/20). "Press Release: Metrion Biosciences Strengthens Global Business Development Team". Cambridge. |
2020-09-08 |
| Metronomia Clinical Research GmbH. (7/1/20). "Press Release: Denise Lee Joins Metronomia as Managing Director". |
2020-07-01 |
| MGB Biopharma Ltd.. (4/6/17). "Press Release: MGB Biopharma Closes $1 Million Financing Round to Finance Manufacturing of MGB-BP-3 for Phase II Study in Clostridium difficile-Associated Disease (CDAD)". Glasgow. |
2017-04-06 |
| Micro-Sphere S.A.. (8/22/17). "Press Release: CDMO to Invest €19m in GMP Facility Expansion". |
2017-08-22 |
| Microbiotica Ltd.. (10/24/18). "Press Release: Microbiotica Attracts Equity Investment from Seventure’s Health for Life Capital Fund". Cambridge. |
2018-10-24 |
| Microbiotica Ltd.. (3/7/22). "Press Release: Microbiotica Raises £50 Million ($67 Million) to Advance Pipeline of Microbiome-based Therapeutics". Cambridge. |
2022-03-07 |
| Microbiotica Ltd.. (5/9/17). "Press Release: Microbiotica Appoints John Shields as Non-Executive Director". |
2017-05-09 |
| Microbiotica Ltd.. (6/6/18). "Press Release: Microbiotica Enters into Microbiome Collaboration with Genentech". Cambridge. |
2018-06-06 |
| MicrofluidX Ltd.. (12/8/22). "Press Release: MicrofluidX Raises £3.3 Million to Develop Their Next Generation Advanced Therapy Manufacturing Platform". Stevenage. |
2022-12-08 |
| MicrofluidX Ltd.. (5/2/23). "Press Release: MicrofluidX and Immatics Working Together on Automated End-to-End Bioprocessing for TCR-T Therapies". Stevenage & Houston, TX. |
2023-05-02 |
| Microsaic Systems plc. (1/24/17). "Press Release: Appointment of Interim Chairman". |
2017-01-24 |
| Microsaic Systems plc. (3/15/18). "Press Release: Final Results for the Year Ended 31 December 2017". |
2018-03-15 |
| Microsaic Systems plc. (3/21/17). "Press Release: Audited Financial Results for the Year Ended 31 December 2016". |
2017-03-21 |
| Microsaic Systems plc. (3/23/18). "Press Release: Microsaic Signs Commercial Contract with CPI Innovation Services Ltd". |
2018-03-23 |
| Microsaic Systems plc. (3/28/18). "Press Release: Agreement with Unimicro Technologies Inc". |
2018-03-28 |
| Microsaic Systems plc. (4/10/18). "Press Release: Microsaic Systems Launches 4500 MiD for Point-of-need Mass Spectrometry at Analytica 2018". |
2018-04-10 |
| Microsaic Systems plc. (4/12/18). "Press Release: Microsaic Signs Agreement with Knauer". |
2018-04-12 |
| Microsaic Systems plc. (4/26/17). "Press Release: Integration with SCPA Chromatography Software". |
2017-04-26 |
| Microsaic Systems plc. (4/7/17). "Press Release: Microsaic Signs Amended Agreement with Global Partner". |
2017-04-07 |
| Microsaic Systems plc. (5/11/17). "Press Release: Microsaic Enhances Capabilities of Its 4000 MiD Miniaturised Mass Spectrometer for Bioprocessing Applications". |
2017-05-11 |
| Microsaic Systems plc. (5/24/18). "Press Release: Distribution Agreement with Stable Arm Sdn. Bhd.". |
2018-05-24 |
| Microsaic Systems plc. (5/9/18). "Press Release: Microsaic Signs Agreement with Rightek Co., Ltd.". |
2018-05-09 |
| Microsaic Systems plc. (6/13/18). "Press Release: Distribution Agreement with Omicron Research Ltd.". |
2018-06-13 |
| Microsaic Systems plc. (6/21/18). "Press Release: Distribution Agreement with Amedis, spol. s ro.". |
2018-06-21 |
| Microsaic Systems plc. (6/5/18). "Press Release: Fundraising [NOT FOR UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH PROHIBITED]". |
2018-06-05 |
| Microsaic Systems plc. (6/5/18). "Press Release: PrimaryBid.com Offer [NOT FOR UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH PROHIBITED]". |
2018-06-05 |
| Microsaic Systems plc. (6/6/18). "Press Release: Successful Fundrainsing of £5.5 Million [N OT FOR RELEASE IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL]". |
2018-06-06 |
| Microsaic Systems plc. (9/25/17). "Press Release: Appointment of Chief Executive Officer". |
2017-09-25 |
| miDiagnostics N.V.. (4/30/21). "Press Release: miDiagnostics Accelerates with Launch of Rapid COVID-19 PCR Test Product". Leuven. |
2021-04-30 |
| MiNA Therapeutics Ltd.. (1/21/21). "Press Release: Servier and MiNA Therapeutics Enter Collaboration in Neurological Diseases". Paris & London. |
2021-01-21 |
| MiNA Therapeutics Ltd.. (1/5/21). "Press Release: MiNA Therapeutics Appoints Robin Wright as Chief Financial Officer". London. |
2021-01-05 |
| MiNA Therapeutics Ltd.. (1/7/20). "Press Release: MiNA Therapeutics Announces Research Collaboration with AstraZeneca in Metabolic Diseases". London. |
2020-01-07 |
| MiNA Therapeutics Ltd.. (5/3/17). "Press Release: Sosei Pays GBP 35 Million for an Equity Stake and Acquisition Option Agreement in MiNA Therapeutics". Tokyo & London. |
2017-05-03 |
| MiNA Therapeutics Ltd.. (9/10/20). "Press Release: MiNA Therapeutics Secures £23 Million Series A Financing to Advance First-in-Class Activating RNA-Based Therapeutics". London. |
2020-09-10 |
| MiNA Therapeutics Ltd.. (9/29/20). "Press Release: MiNA Therapeutics Appoints Peter Bains as Chief Business Officer". London. |
2020-09-29 |
![[LSUK] Life-Sciences-UK.com - The UK Life Sciences Web Portal](/images/basics/lsuk-life-sciences-uk-portal-logo.svg){kind=logo}
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
